/EINPresswire.com/ -- SAN ANTONIO, TEXAS -- (Marketwired) -- 08/03/16 -- Nerium Biotechnology, Inc. ("Nerium" or the "Company") reported today that it has filed an application in Hong Kong seeking an injunction against Nerium International, LLC (the "Distributor") and its subsidiary Nerium International Hong Kong Limited. As with other actions commenced by the Company in the courts of Texas and the United States federal courts, the Company is acting to protect its intellectual property against infringement by the Distributor and to prevent other actions that would constitute a breach of the Company Agreement that governs the Distributor.

The Distributor was formed to act as a distributor of certain products researched, developed, and produced by Nerium and its subsidiary Nerium SkinCare, Inc. ("Nerium SkinCare"). Through Nerium SkinCare, the Company holds a minority ownership interest in the Distributor. The majority ownership interest in the Distributor is held by JO Products, a company controlled by the Distributor's sole manager, Jeff Olson.

The Company filed its application in response to the Distributor's recent actions in Hong Kong, including its application to register trademarks containing the word "Nerium" and its attempt to invalidate the Company's trademark "NeriumAD" in Hong Kong. The Company is seeking an injunction against the Distributor and its Hong Kong subsidiary to restrain them from infringing the Company's trademarks, acting in breach of the Company Agreement and committing the tort of passing off in Hong Kong.

About Nerium Biotechnology, Inc.

Nerium Biotechnology, Inc. is a biotechnology company involved in the research, product development, manufacture and marketing of Nerium oleander-based products. The Company's shares are not listed on any stock exchange or quotation system.

Forward Looking Statements: Statements made in this news release that relate to future plans, expectations, events or performances are forward looking statements. Such statements are based on current expectations and involve risks and uncertainties. There can be no certainty about the outcome of any litigation, including the Company's actions against Nerium International LLC and Nerium International Hong Kong Limited, and such litigation could have an adverse effect on the Company's business, financial condition, results of operation and cash flows.

Contacts:
Joseph B. Nester, Executive Vice-President
210-822-7908 (ext. 101)
jnester@neriumbiotech.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.